Powered by
GRAND RAPIDS—Officials at Tetra Therapeutics, a pharma startup developing drugs to treat brain disorders associated with cognitive and memory deficits, announced that CEO Mark Gurney had retired effective June 30. …
GRAND RAPIDS—The Grand Rapids-based pharmaceutical startup Tetra Therapeutics announced that new preclinical research suggests the ability of its investigational drug, BPN14770, to protect against memory loss and neuronal atrophy induced …
GRAND RAPIDS—Tetra Discovery Partners, a clinical-stage biotechnology company, announced the company’s name change to Tetra Therapeutics. The name change reflects the company’s transition from a company focused on discovery research …